358 related articles for article (PubMed ID: 25744365)
41. Association of leptin receptor polymorphisms with susceptibility of non-small cell lung cancer: Evidence from 2249 subjects.
Tang W; Wang J; Dai T; Qiu H; Liu C; Chen S; Hu Z
Cancer Med; 2024 Apr; 13(8):e7178. PubMed ID: 38659416
[TBL] [Abstract][Full Text] [Related]
42. The genetic variations in DNA repair genes ERCC2 and XRCC1 were associated with the overall survival of advanced non-small-cell lung cancer patients.
Wang S; Wang J; Bai Y; Wang Q; Liu L; Zhang K; Hong X; Deng Q; Zhang X; He M; Wu T; Xu P; Guo H
Cancer Med; 2016 Sep; 5(9):2332-42. PubMed ID: 27465648
[TBL] [Abstract][Full Text] [Related]
43. Gene polymorphism of DNA repair gene X-ray repair cross complementing group 1 and xeroderma pigmentosum group D and environment interaction in non-small-cell lung cancer for Chinese nonsmoking female patients.
Wang L; Wang LL; Shang D; Yin SJ; Sun LL; Wang XY; Ji HB
Kaohsiung J Med Sci; 2019 Jan; 35(1):39-48. PubMed ID: 30844146
[TBL] [Abstract][Full Text] [Related]
44. IL1B gene polymorphisms, age and the risk of non-small cell lung cancer in a Chinese population.
Li Y; Zhao W; Zhao Z; Wu J; Chen L; Ma Y; Li Q; Lu D; Jin L; Wang J
Lung Cancer; 2015 Sep; 89(3):232-7. PubMed ID: 26141218
[TBL] [Abstract][Full Text] [Related]
45. Association between EGF +61 genetic polymorphisms and non-small cell lung cancer increased risk in a Portuguese population: a case-control study.
de Mello RA; Ferreira M; Costa S; Costa BM; Pires FS; Neves I; Almeida MI; Cunha J; Oliveira P; Hespanhol V; Reis RM
Tumour Biol; 2012 Oct; 33(5):1341-8. PubMed ID: 22457050
[TBL] [Abstract][Full Text] [Related]
46. Clinical Implication of EGF A61G Polymorphism in the Risk of Non Small Cell Lung Adenocarcinoma Patients: A Case Control Study.
Masroor M; Amit J; Javid J; Mir R; Prasant Y; Imtiyaz A; Mariyam Z; Mohan A; Ray PC; Saxena A
Asian Pac J Cancer Prev; 2015; 16(17):7529-34. PubMed ID: 26625757
[TBL] [Abstract][Full Text] [Related]
47. Polymorphisms in EGFR and VEGF contribute to non-small-cell lung cancer survival in a Chinese population.
Dong J; Dai J; Shu Y; Pan S; Xu L; Chen W; Wang Y; Jin G; Ma H; Zhang M; Hu Z; Shen H
Carcinogenesis; 2010 Jun; 31(6):1080-6. PubMed ID: 20400478
[TBL] [Abstract][Full Text] [Related]
48. MiR-146a polymorphism correlates with lung cancer risk in Chinese nonsmoking females.
Yin Z; Cui Z; Ren Y; Xia L; Li H; Zhou B
Oncotarget; 2017 Jan; 8(2):2275-2283. PubMed ID: 27911870
[TBL] [Abstract][Full Text] [Related]
49. CLPTM1L polymorphism as a protective factor for lung cancer: a case-control study in southern Chinese population.
Jin T; Li B; He N; Zhang Y; Xia R; Kang L; Ding Y; Yuan D
Tumour Biol; 2016 Aug; 37(8):10533-8. PubMed ID: 26852039
[TBL] [Abstract][Full Text] [Related]
50. Association of
Wang J; Chen Z; Cao R; Zhang Q; Chen T; You C; Tang W; Chen S
Biomed Res Int; 2021; 2021():9121824. PubMed ID: 33564688
[TBL] [Abstract][Full Text] [Related]
51. Association between insulin-like growth factor binding protein-3 promoter polymorphism of -1590 C>A and lung cancer susceptibility in a Chinese Han population.
Dai X; Liu Z; Ren J; Wu G
Genet Test Mol Biomarkers; 2011 May; 15(5):301-6. PubMed ID: 21254935
[TBL] [Abstract][Full Text] [Related]
52. Association of miR-502-binding site single nucleotide polymorphism in the 3'-untranslated region of SET8 and TP53 codon 72 polymorphism with non-small cell lung cancer in Chinese population.
Yang S; Guo H; Wei B; Zhu S; Cai Y; Jiang P; Tang J
Acta Biochim Biophys Sin (Shanghai); 2014 Feb; 46(2):149-54. PubMed ID: 24374662
[TBL] [Abstract][Full Text] [Related]
53. The relationship between genetic variants of XRCC1 gene and lung cancer susceptibility in Chinese Han population.
Tang J; Zhao J; Zhao J
Med Oncol; 2014 Sep; 31(9):157. PubMed ID: 25146668
[TBL] [Abstract][Full Text] [Related]
54. Tankyrase 2 (TNKS2) polymorphism associated with risk in developing non-small cell lung cancer in a Chinese population.
Wang Y; Jiang W; Liu X; Zhang Y
Pathol Res Pract; 2015 Oct; 211(10):766-71. PubMed ID: 26293798
[TBL] [Abstract][Full Text] [Related]
55. Association of polymorphisms at HORMAD2 and prognosis in advanced non-small-cell lung cancer patients.
Zhang K; Tang S; Cao S; Hu L; Pan Y; Ma H; Guo X; Wu S; Shen H; Hu Z
Cancer Epidemiol; 2014 Aug; 38(4):414-8. PubMed ID: 24797335
[TBL] [Abstract][Full Text] [Related]
56. CTLA-4 +49A>G polymorphism is associated with advanced non-small cell lung cancer prognosis.
Song B; Liu Y; Liu J; Song X; Wang Z; Wang M; Zhu Y; Han J
Respiration; 2011; 82(5):439-44. PubMed ID: 21832820
[TBL] [Abstract][Full Text] [Related]
57. Association between polymorphisms in COMT, PLCH1, and CYP17A1, and non-small-cell lung cancer risk in Chinese nonsmokers.
Zhang Y; Hua S; Zhang A; Kong X; Jiang C; Deng D; Wenlong B
Clin Lung Cancer; 2013 Jan; 14(1):45-9. PubMed ID: 22658813
[TBL] [Abstract][Full Text] [Related]
58. Polymorphism in PHD1 gene and risk of non-small cell lung cancer in a Chinese population.
Che J; Jiang D; Zheng Y; Zhu B; Zhang P; Lu D; Zhang J; Xiao J; Wang J; Gao Y; Yan X; Wang M
Tumour Biol; 2014 Sep; 35(9):8921-5. PubMed ID: 24894671
[TBL] [Abstract][Full Text] [Related]
59. Interleukin 17A genetic variations and susceptibility to non-small cell lung cancer.
Ma QY; Chen J; Wang SH; Wu N; Hao ZH; Chen XF
APMIS; 2015 Mar; 123(3):194-8. PubMed ID: 25469655
[TBL] [Abstract][Full Text] [Related]
60. Genetic variants of JNK and p38α pathways and risk of non-small cell lung cancer in an Eastern Chinese population.
Jia M; Zhu M; Zhou F; Wang M; Sun M; Yang Y; Wang X; Wang J; Jin L; Xiang J; Zhang Y; Chang J; Wei Q
Int J Cancer; 2017 Feb; 140(4):807-817. PubMed ID: 27861856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
